Abstract
ObjectivesTransition from originator biological medicines to their biosimilar equivalents is now part of routine clinical practice, but there is little understanding of patient experiences, which influence adherence and overall satisfaction...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have